NO20041921L - Peroksisom proliferator-aktivert reseptorligand og fremgangsmate for fremstilling av denne - Google Patents

Peroksisom proliferator-aktivert reseptorligand og fremgangsmate for fremstilling av denne

Info

Publication number
NO20041921L
NO20041921L NO20041921A NO20041921A NO20041921L NO 20041921 L NO20041921 L NO 20041921L NO 20041921 A NO20041921 A NO 20041921A NO 20041921 A NO20041921 A NO 20041921A NO 20041921 L NO20041921 L NO 20041921L
Authority
NO
Norway
Prior art keywords
activated receptor
peroxisome proliferator
receptor ligand
preparation
ligand
Prior art date
Application number
NO20041921A
Other languages
English (en)
Other versions
NO20041921D0 (no
Inventor
Yasuyoshi Ueda
Tatsumasa Mae
Misuzu Tsukagawa
Mikio Kitahara
Kaku Nakagawa
Shiro Kitamura
Yutaka Sahida
Minpei Kuroda
Yoshihiro Mimaki
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of NO20041921D0 publication Critical patent/NO20041921D0/no
Publication of NO20041921L publication Critical patent/NO20041921L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)

Abstract

Den foreliggende oppfinnelsen tilveiebringer lett og effektiv en peroksisom proliferator-aktivert reseptorligand og en sammensetning for forbedring av insulinresistens eller for hindring og/eller forbedring av insulinresistens syndromet inneholdende denne som en aktiv ingrediens.Den foreliggende oppfinnelsen vedrører en peroksisom proliferator-aktivert reseptorligand som omfatter en prenylflavonoid, et kalkonderivat eksklusiv prenylflavonoider, et flavonolderivat eksklusiv prenylflavonoider og et salt, et glykosid og/eller en estrifisert substans derav akseptabel som et farmasøytisk preparat eller matvare eller en drikk, en sammensetning inneholdende ovennevnte ligand, et plateavledet ekstrakt inneholdende den ovenfor nevnte liganden og en fremgangsmåte for fremstilling av det ovenfor nevnte ekstraktet.
NO20041921A 2001-10-11 2004-05-10 Peroksisom proliferator-aktivert reseptorligand og fremgangsmate for fremstilling av denne NO20041921L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2001313816 2001-10-11
JP2002006304 2002-01-15
JP2002042466 2002-02-20
JP2002226486 2002-08-02
PCT/JP2002/010572 WO2003037316A1 (en) 2001-10-11 2002-10-11 Peroxisome proliferator activated receptor ligands and process for producing the same

Publications (2)

Publication Number Publication Date
NO20041921D0 NO20041921D0 (no) 2004-05-10
NO20041921L true NO20041921L (no) 2004-07-06

Family

ID=27482611

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041921A NO20041921L (no) 2001-10-11 2004-05-10 Peroksisom proliferator-aktivert reseptorligand og fremgangsmate for fremstilling av denne

Country Status (9)

Country Link
US (2) US7524975B2 (no)
EP (1) EP1440688A4 (no)
JP (1) JPWO2003037316A1 (no)
KR (1) KR20050035142A (no)
CN (1) CN1599602A (no)
CA (1) CA2460134A1 (no)
IL (1) IL160964A0 (no)
NO (1) NO20041921L (no)
WO (1) WO2003037316A1 (no)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200416037A (en) * 2002-02-20 2004-09-01 Kanegafuchi Chemical Ind Process for producing hydrophobic glycyrrhiza extract with high qualities
TW200427410A (en) * 2003-01-24 2004-12-16 Kaneka Corp Processed fat compositions for preventing and improving lifestyle-related diseases
TW200509886A (en) * 2003-05-02 2005-03-16 Takara Bio Inc Therapeutic agent
WO2005002672A2 (en) 2003-07-01 2005-01-13 President And Fellows Of Harvard College Sirt1 modulators for manipulating cells/organism lifespan/stress response
TW200513194A (en) * 2003-07-31 2005-04-16 Kaneka Corp Fat and oil processed composition for prevention and/or amelioration of life-style related disease
WO2005039727A1 (en) * 2003-10-24 2005-05-06 Native Fire Actives Pty Ltd Extraction process
DE10357452A1 (de) * 2003-12-03 2005-06-30 Beiersdorf Ag Kosmetische Zubereitungen mit einem Gehalt an Licochalcon A oder einem Extrakt aus Radix Glycyrrhizae inflatae, enthaltend Licochalcon A, und organischen Verdicker
AU2004312072B2 (en) 2003-12-29 2011-06-23 President And Fellows Of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
US8017634B2 (en) * 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
KR20060132903A (ko) 2004-01-08 2006-12-22 장피트 1,3-디페닐프로프-2-엔-1-온 유도체 화합물, 그 제조방법및 용도
JPWO2005074906A1 (ja) * 2004-02-06 2008-01-10 タカラバイオ株式会社 治療剤
JP2005320281A (ja) * 2004-05-10 2005-11-17 Shiratori Pharmaceutical Co Ltd インスリン分泌促進剤及び飲食品
TW200612902A (en) * 2004-05-13 2006-05-01 Kaneka Corp Inhibiting agents for lipase or cholesterol esterase, and absorption suppressing agents for neutral fat, cholesterol, or cholesterol ester
US20060040876A1 (en) * 2004-06-10 2006-02-23 Rong-Hwa Lin Modulation of peroxisome proliferator-activated receptors
US7588788B2 (en) * 2004-07-23 2009-09-15 Wholesome Life Science Co., Ltd. Immune modulation and anti-allergy activities of Zingiber zerumbet
CN101052391A (zh) * 2004-11-08 2007-10-10 爱科来株式会社 过氧化物酶体增殖物激活受体（ppar）活化剂以及使用了该活化剂的药品、补充剂、功能性食品和食品添加剂
WO2006085562A1 (ja) * 2005-02-09 2006-08-17 Kaneka Corporation メタボリックシンドローム及びインスリン抵抗性症候群の予防及び／又は処置用組成物
US20090041876A1 (en) * 2005-03-30 2009-02-12 Kaneka Corporation Oil/fat-containing composition for suppression of carcinogenesis
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
KR20080019242A (ko) * 2005-06-24 2008-03-03 디에스엠 아이피 어셋츠 비.브이. 글루코스 대사부전 치료용 약제
US20070149466A1 (en) * 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
JP2007063161A (ja) * 2005-08-30 2007-03-15 Kaneka Corp 急性相反応タンパク質転写抑制活性剤。
JP2007119429A (ja) * 2005-10-31 2007-05-17 Ichimaru Pharcos Co Ltd ペルオキシソーム増殖剤応答性受容体活性化剤
JP4732854B2 (ja) * 2005-10-31 2011-07-27 一丸ファルコス株式会社 ペルオキシソーム増殖剤応答性受容体活性化剤
JP4954531B2 (ja) * 2005-10-31 2012-06-20 一丸ファルコス株式会社 ペルオキシソーム増殖剤応答性受容体活性化剤
KR20070052211A (ko) * 2005-11-16 2007-05-21 주식회사 엠디바이오알파 글라브리딘을 유효성분으로 함유하는 질환 증후군 예방 및치료용 조성물
WO2007060992A1 (ja) * 2005-11-25 2007-05-31 Kaneka Corporation メタボリックシンドロームもしくはインスリン抵抗性症候群の予防または改善剤
JP5246833B2 (ja) * 2005-12-16 2013-07-24 独立行政法人産業技術総合研究所 アディポネクチン産生増強剤
JP5246834B2 (ja) * 2005-12-27 2013-07-24 独立行政法人産業技術総合研究所 アディポネクチン産生強化剤
JP5158742B2 (ja) * 2006-11-10 2013-03-06 独立行政法人産業技術総合研究所 炎症性インターロイキン産生抑制剤
CN110403942A (zh) * 2007-04-11 2019-11-05 奥默罗斯公司 预防和治疗成瘾的组合物和方法
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US20080274063A1 (en) * 2007-05-02 2008-11-06 Chantal Bergeron Supercritical CO2 liquorice extract anti-microbial and anti-inflammatory isolates and products made there from
US8236360B2 (en) * 2007-05-02 2012-08-07 Tom's Of Maine, Inc. Supercritical CO2 liquorice extract and products made there from
US8877266B2 (en) 2007-05-02 2014-11-04 Tom's Of Maine, Inc. Supercritical CO2 liquorice extract anti-microbial and anti-inflammatory isolates and products made there from
JPWO2008143182A1 (ja) * 2007-05-17 2010-08-05 株式会社カネカ 甘草ポリフェノールを含有する組成物
JP2009001523A (ja) * 2007-06-22 2009-01-08 Maruzen Pharmaceut Co Ltd 抗男性ホルモン剤、育毛剤及び頭髪化粧料
JP5364580B2 (ja) 2007-08-22 2013-12-11 株式会社カネカ 還元型補酵素ｑ１０の製造方法、ならびに、その安定化方法
WO2009026657A1 (en) * 2007-08-29 2009-03-05 The University Of Sydney Flavonoid ppar agonists
CN101434592B (zh) * 2008-12-19 2014-06-25 沈阳药科大学 朝鲜槐中提取的黄酮类化合物
KR101052594B1 (ko) 2009-03-10 2011-07-29 한국생명공학연구원 디아실 코에이:글리세롤 아실트랜스퍼라제 저해활성을 갖는감초 추출물, 이의 용매분획물 또는 이로부터 분리된 화합물을 포함하는 조성물
KR101034624B1 (ko) * 2009-06-17 2011-05-12 울산대학교 산학협력단 디디에이에이치를 활성화시키는 감초 유래의 칼콘 화합물 및 이를 유효성분으로 하는 췌장 베타세포 사멸 및 당뇨병성 신증의 예방 또는 치료용 조성물
NO2571843T3 (no) 2010-05-17 2018-05-26
MX354133B (es) 2010-08-18 2018-02-14 Samumed Llc Dicetonas e hidroxicetonas como activadores de la trayectoria de señalizacion de catenina.
JP6010281B2 (ja) * 2011-03-03 2016-10-19 株式会社カネカ 筋肉増量剤
CN103608024B (zh) 2011-04-01 2016-04-13 桂林商源植物制品有限公司 控制血糖、血脂及体重的药物组合物
KR101060942B1 (ko) * 2011-04-21 2011-08-30 경희대학교 산학협력단 리코찰콘 ａ의 신규 용도
EP2721003B1 (en) 2011-06-15 2018-01-03 The United States of America, as Represented by The Secretary, Department of Health and Human Services Nuclear receptor modulators and their use for the treatment and prevention of cancer
TWI417088B (zh) 2011-08-10 2013-12-01 Univ Kaohsiung Medical 用於治療糖尿病及新陳代謝疾病的組合物及其製備方法
JP6036193B2 (ja) * 2012-11-09 2016-11-30 国立大学法人富山大学 インフラマソーム活性制御剤
EP3456325A3 (en) 2013-02-22 2019-05-22 Samumed, LLC Gamma-diketones as wnt/beta-catenin signalling pathway activators
JP6245867B2 (ja) * 2013-07-05 2017-12-13 ソマール株式会社 ＰＰＡＲγ活性向上剤及びそれを用いた経口組成物
CN103565800B (zh) * 2013-10-30 2015-06-17 中国农业大学 甘草香豆素在制备用于预防/治疗酒精性肝损伤的产品中的应用
KR102344479B1 (ko) * 2013-12-24 2021-12-29 주식회사 글라세움 피라노크로메닐페놀 유도체, 및 대사증후군 또는 염증 질환 치료용 약학 조성물
JP6289218B2 (ja) * 2014-03-31 2018-03-07 大阪瓦斯株式会社 ＰＰＡＲα活性組成物の活性化方法
US10045540B2 (en) 2014-04-01 2018-08-14 Fayetteville State University Pest control composition
SI3206686T1 (sl) 2014-08-20 2020-03-31 Samumed, Llc Gama-diketoni za zdravljenje in preprečevanje staranja kože in gub
CN105232501B (zh) * 2015-11-17 2019-01-08 北京大学 刺甘草査尔酮的用途
CN105582005B (zh) * 2015-12-11 2018-06-19 北京大学 甘草中一类异戊烯基异黄酮类化合物的医药用途
CN105963291B (zh) * 2016-06-02 2019-05-24 上海中医药大学 异补骨脂二氢黄酮及其类似物的医药用途
BR112018077392A2 (pt) * 2016-06-29 2019-04-09 Glaceum, Inc. composição farmacêutica e derivado de piranocromenil fenol oticamente ativo compreendendo a mesma
CN106580951B (zh) * 2016-11-17 2019-07-30 珠海雅光生物工程有限公司 一种黄烷酮化合物的新用途
CN108997296B (zh) * 2018-08-18 2022-02-18 内蒙古大学 几种异戊烯基二氢茋和异戊烯基黄酮的结构和用途
CN110872306B (zh) * 2018-08-30 2022-03-22 复旦大学 一种从藤构中提取的化合物及其在制药中的用途
CN110872267B (zh) * 2018-08-30 2022-07-08 复旦大学 一种从构树中提取的化合物及其在制备蛋白酪氨酸磷酸酶1b抑制剂中的用途
CN109223762A (zh) * 2018-09-26 2019-01-18 兰州大学第医院 光甘草素在制备抗癌药物中的应用
CN109232603B (zh) * 2018-10-29 2020-12-22 陕西师范大学 一种光甘草定的合成方法
WO2020153413A1 (ja) * 2019-01-22 2020-07-30 株式会社 沖縄リサーチセンター ＰＰＡＲγ活性化用組成物及び糖取込み促進能向上用組成物
CN110772504B (zh) * 2019-02-27 2021-06-22 中国人民解放军总医院第五医学中心 刺甘草查尔酮作为抑制剂的用途
CN110025603A (zh) * 2019-05-15 2019-07-19 大连天星本草生物科技有限公司 补骨脂查尔酮类化合物在制备治疗肥胖症的药物中的应用
CN111714489A (zh) * 2019-12-10 2020-09-29 德萌达生物医药科技(杭州)有限公司 对肿瘤具有杀伤作用的双拓扑异构酶抑制剂及其制备方法
EP4205737A4 (en) * 2020-08-05 2024-07-31 University-Industry Cooperation Group Of Kyung Hee University Composition for prevention, amelioration, or treatment of inflammatory diseases or immune diseases comprising gancaonin n as active ingredient
CN112047916A (zh) * 2020-09-21 2020-12-08 苏州昊帆生物股份有限公司 异甘草黄酮醇的合成方法
CN112791081A (zh) * 2021-01-26 2021-05-14 云南农业大学 怀特酮在制备肺癌治疗药物中的应用
CN113332294A (zh) * 2021-05-25 2021-09-03 成都中医药大学 一种中药甘草抗肿瘤活性成分配伍组合物
CN114031625B (zh) * 2021-11-22 2023-05-30 兰州大学 甘草中具有抗结直肠癌活性的化合物制备及其应用
WO2025037604A1 (ja) * 2023-08-15 2025-02-20 エムジーファーマ株式会社 脂肪分解及び／又は体重減少に対する内用組成物、有効性を判定する方法、並びに植物抽出物の品質の指標
CN117603175B (zh) * 2023-11-27 2024-08-06 南开大学 一种苯并吡喃结构的查尔酮类衍生物及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940011244B1 (ko) * 1988-11-25 1994-12-03 다이닛뽕잉끼 가가꾸 고오교오 가부시끼가이샤 신장 질환 치료제
JP2753719B2 (ja) 1988-12-15 1998-05-20 日本油脂株式会社 リポソーム製剤の製造法
JPH0368157A (ja) * 1989-08-05 1991-03-25 Mitsubishi Electric Corp 高周波用厚膜集積回路装置
JPH0368517A (ja) * 1989-08-08 1991-03-25 Tsumura & Co アルドースリダクターゼ阻害剤
JPH04297418A (ja) * 1991-02-07 1992-10-21 Sumitomo Metal Ind Ltd 血小板凝集抑制剤および白血球活性化抑制剤
EP0499015A1 (en) * 1991-02-15 1992-08-19 Fockerman, Jasmine Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents
JP3052104B2 (ja) * 1992-11-19 2000-06-12 丸善製薬株式会社 皮膚化粧料
JPH07165588A (ja) * 1993-12-13 1995-06-27 Tsumura & Co 脳機能改善剤
JPH0873337A (ja) 1994-09-07 1996-03-19 Ogawa Koryo Kk 外用剤組成物
US6251400B1 (en) 1997-09-26 2001-06-26 Kgk Synergize Inc Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols
JP3069686B2 (ja) 1997-12-08 2000-07-24 農林水産省四国農業試験場長 フラバノン類含有組成物
EP1057825A4 (en) * 1998-01-27 2001-10-24 Shionogi & Co ISOFLAVANE DERIVATIVES AND IMMUNOSTIMULATING COMPOSITIONS CONTAINING THEM
JP3648587B2 (ja) * 1998-03-04 2005-05-18 サンスター株式会社 歯周病予防又は歯周病進行予防食品組成物
JP3542284B2 (ja) * 1998-09-08 2004-07-14 シマノ シンガポール ピーティーイー．リミテッド． 釣り用リール
JP2982872B1 (ja) * 1998-09-10 1999-11-29 有限会社松川化学 痩身用皮膚外用剤
KR20000019716A (ko) * 1998-09-15 2000-04-15 박호군 바이오플라보노이드 화합물을 포함하는 혈당 강하용 조성물
JP4418550B2 (ja) 1999-02-17 2010-02-17 丸善製薬株式会社 疎水性甘草エキス含有組成物
JP2000355538A (ja) 1999-04-15 2000-12-26 Kanegafuchi Chem Ind Co Ltd ペルオキシゾーム活性化剤応答性受容体アゴニスト
KR20020070508A (ko) 2000-01-28 2002-09-09 노보 노르디스크 에이/에스 프로피온산 유도체 및 당뇨병 및 비만의 치료에 그것의 사용
KR100472694B1 (ko) * 2000-12-30 2005-03-07 한국생명공학연구원 플라바논 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물

Also Published As

Publication number Publication date
WO2003037316A1 (en) 2003-05-08
US20090036519A1 (en) 2009-02-05
KR20050035142A (ko) 2005-04-15
CA2460134A1 (en) 2003-05-08
US20050014819A1 (en) 2005-01-20
JPWO2003037316A1 (ja) 2005-02-17
NO20041921D0 (no) 2004-05-10
IL160964A0 (en) 2004-08-31
EP1440688A4 (en) 2005-11-30
EP1440688A1 (en) 2004-07-28
CN1599602A (zh) 2005-03-23
US7888388B2 (en) 2011-02-15
US7524975B2 (en) 2009-04-28

Similar Documents

Publication Publication Date Title
NO20041921L (no) Peroksisom proliferator-aktivert reseptorligand og fremgangsmate for fremstilling av denne
Demir et al. Antidiabetic properties of dietary phenolic compounds: Inhibition effects on α‐amylase, aldose reductase, and α‐glycosidase
Manach et al. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
Yáñez et al. Polyphenols and flavonoids: an overview
CA2342608A1 (en) Bioflavonoid as blood glucose level lowering agent
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
BR0207731A (pt) Formulação cosmética compreendendo derivados de flavonóide
Pistelli et al. Antimicrobial properties of flavonoids
WO1999066913A3 (en) Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein
BRPI0509724A (pt) composição flavorizante, uso de uma substáncia, produto, e, processo para melhorar o sabor de um alimento, uma bebida, um produto farmacêutico ou um produto de cuidado oral
Gandhi et al. Medicinal plants and natural molecules with in vitro and in vivo activity against rotavirus: A systematic review
BR0112417A (pt) Composições farmacêuticas contendo composto dds
CA2849473A1 (en) Selective metabolic approach to increasing oral bioavailability of phenylephrine and other phenolic bioactives
BR0308338A (pt) Derivados de nitrosodifenilamina e seu uso farmacêutico contra patologias de estresse oxidativo
Siwak et al. Protection of flavonoids against hypochlorite-induced protein modifications
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
BR0113463A (pt) Composição farmacêutica para o tratamento e/ou prevenção de infecções clamidiais, composição pró-saúde e seu uso
ATE372776T1 (de) Arzneimittel enthaltend deuterium zur behandlung der zuckerkrankheit
Epstein Cosmeceuticals and polyphenols
JP2015023871A (ja) 苦味及び／又は渋味がマスキングされたポリフェノール含有飲食品
EP2050442A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF BONE DISORDERS, FUNCTIONAL FOOD OR HEALTH MEASURES CONTAINING THIS COMPOSITION AND PHARMACEUTICAL PREPARATION CONTAINING THE COMPOSITION AS AN ACTIVE SUBSTANCE
KR20130071032A (ko) 단삼 추출물을 포함하는 코로나 바이러스 감염의 예방 또는 치료용 조성물
EP1312373A4 (en) ANTI-ALLERGIC COMPOUNDS AND THE MEDICINES, FOODS, DRINKS OR COSMETICS CONTAINING THEM, AND METHOD FOR THE PRODUCTION THEREOF
Sen et al. Extraction, isolation, and quantitative determination of flavonoids by HPLC
Fazadini et al. In silico study: The blue butterfly pea flower (Clitoria ternatea L.) compound has potential for herbal medicine for COVID-19

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application